{"title":"Immune Booster","description":"","products":[{"product_id":"scitron","title":"Scitron","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003cp data-mce-fragment=\"1\"\u003e\u003cstrong\u003eOBJECTIVES:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003ePersonalized \u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cul\u003e\n\u003cli\u003eProgrammed as a one-to-one replacement for damaged cells and tissues, making it a tailored approach that can be customized to each individual's specific needs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003ePotential to Improve a Variety of Conditions \u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to potentially enhance well-being in a wide range of conditions, from chronic pain and inflammation to autoimmune diseases and neurological disorders, cost-effectively.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eCell Rejuvenation \u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cul\u003e\n\u003cli\u003eAids in reviving damaged cells and tissues, promoting better overall health and wellness.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eEnhanced Natural Healing \u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cul\u003e\n\u003cli\u003eSupports the body's innate healing processes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cli\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eMultiple Administration Options \u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cul\u003e\n\u003cli\u003eCan be administered through various routes, making it a versatile approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePersonalised. Regenerate. Rejuvenate. Renew.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIntroducing Scitron, the innovative stem cell product that is changing the way we think about healthcare. With its personalized one-to-one cell replacement approach, Scitron has the power to revive damaged cells and tissues, promoting cell rejuvenation and natural healing. Scitron offers versatility with multiple administration options that ensure each approach is tailored to the individual needs of every user. With its potential to regenerate, rejuvenate, and renew specific damaged cells and tissues, Scitron is more than just a product; it's a gateway to renewed health and vitality. Discover the power of Scitron and unlock your body's full regenerative potential today.\u003c\/p\u003e\n\u003cbr\u003e","brand":"Cell Tissue","offers":[{"title":"Medium \/ 1x in 1 week","offer_id":40895665012772,"sku":"CT01CT021","price":5330.9,"currency_code":"MYR","in_stock":true},{"title":"Medium \/ 5x in 5 weeks","offer_id":40428409880612,"sku":"CT01CT022\/2","price":15635.9,"currency_code":"MYR","in_stock":true},{"title":"Medium \/ 12x in 3 months","offer_id":40678249005092,"sku":"CT01CT022\/3","price":31270.9,"currency_code":"MYR","in_stock":true},{"title":"High \/ 1x in 1 week","offer_id":40895665045540,"sku":"CT01CT023","price":6514.9,"currency_code":"MYR","in_stock":true},{"title":"High \/ 5x in 5 weeks","offer_id":40430545207332,"sku":"CT01CT023\/2","price":19544.9,"currency_code":"MYR","in_stock":true},{"title":"High \/ 12x in 3 months","offer_id":40678249037860,"sku":"CT01CT023\/3","price":39088.9,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/products\/Scitron.png?v=1675411706"},{"product_id":"zecatron","title":"ZECATRON™ BIOFILM","description":"\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eOrgan-Specific Transdermal Exosome Technology\u003c\/strong\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e\u003cstrong\u003eZECATRON™ BIOFILM\u003c\/strong\u003e is a locally acting transdermal biofilm developed by \u003cstrong\u003eCell Tissue Group.\u003c\/strong\u003e It is designed to support targeted, organ-specific wellness using \u003cstrong\u003eiPSC-derived exosomes,\u003c\/strong\u003e delivered through the skin via a local, non-systemic pathway.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis product does not depend on oral absorption or bloodstream delivery. Instead, it focuses on \u003cstrong\u003elocal tissue communication\u003c\/strong\u003e, allowing biological signals to work where they are needed without placing unnecessary burden on the digestive system or internal organs.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT ZECATRON™ BIOFILM IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM is a transdermal biofilm applied directly onto the skin. It combines \u003cstrong\u003einduced pluripotent stem cell (iPSC)-derived exosomes\u003c\/strong\u003e with a proprietary botanical adhesive matrix. Each formulation is designed according to an \u003cstrong\u003eorganotherapy concept,\u003c\/strong\u003e where iPSC lines are differentiated toward specific organ profiles, producing exosomes intended to influence that same target organ.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis creates a \u003cstrong\u003eone-to-one relationship\u003c\/strong\u003e between the exosome signal and the organ it is designed to support.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW THE TECHNOLOGY WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eOnce applied to the skin, the botanical bio-adhesive matrix keeps the biofilm in stable contact with the local tissue. The iPSC-derived exosomes interact with the surrounding micro-environment and transmit biological messages through \u003cstrong\u003einterstitial tissue pathways\u003c\/strong\u003e rather than entering the bloodstream.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThrough this local signaling process, organ-specific messages are delivered in a controlled and focused manner. The body then responds using its own natural regulatory mechanisms. No injections are involved, and no oral intake is required.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eORGAN-SPECIFIC IPSC-DERIVED EXOSOMES\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM uses exosomes derived from iPSCs that have been guided toward specific organ lineages. These exosomes function as \u003cstrong\u003ecell-to-cell communication vesicles\u003c\/strong\u003e, carrying regulatory signals rather than pharmacological substances.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBy matching the exosome profile to the intended organ, ZECATRON™ supports more targeted biological interaction while reducing non-specific effects commonly seen with generalized systemic products.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eTRANSDERMAL DELIVERY WITHOUT SYSTEMIC BURDEN\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eOne of the key advantages of ZECATRON™ BIOFILM is that it \u003cstrong\u003ebypasses the gastrointestinal tract, liver, and kidneys.\u003c\/strong\u003e\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eMost oral supplements are exposed to digestion, enzymatic breakdown, and first-pass metabolism. In many cases, only a small fraction of the active components reach circulation, while the rest are metabolized or excreted. This process can also place repeated metabolic stress on the liver and kidneys over time.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM avoids this route entirely. By delivering signals through the skin and local tissue pathways, it:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eAvoids digestive degradation\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eReduces reliance on bloodstream absorption\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eMinimizes metabolic load on the liver and kidneys\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis makes it a more efficient and gentler option for long-term wellness support.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eBOTANICAL BIO-ADHESIVE BIOFILM\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe botanical adhesive compound used in ZECATRON™ BIOFILM is designed to hold the biofilm securely on the skin while allowing gradual, controlled interaction with the underlying tissue. The formulation prioritizes stability, comfort, and consistent contact without aggressive penetration into blood vessels.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eINTENDED WELLNESS SUPPORT AREAS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM is developed as a \u003cstrong\u003ewellness support product. \u003c\/strong\u003eDepending on the formulation, it may support:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eSkin Health \u0026amp; Brightening\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports skin glow, elasticity, antioxidant protection, and healthy aging\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eEye Health \u0026amp; Vision Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports eye fatigue relief, retinal health, and oxidative protection\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eWeight \u0026amp; Metabolic Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports fat metabolism, appetite regulation, and metabolic balance\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eMen’s Health \u0026amp; Vitality\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports male energy, circulation, stamina, and hormonal balance\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eWomen’s Wellness \u0026amp; Menopause Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports hormonal balance, mood, and menopausal comfort\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eBrain, Memory \u0026amp; Cognitive Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports focus, memory, mental clarity, and brain circulation\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eSleep \u0026amp; Relaxation\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports sleep quality, relaxation, and nervous system calm\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eEnergy \u0026amp; Daily Performance\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports sustained energy without oral stimulants\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eImmune System Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports immune resilience and general defense mechanisms\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eJoint, Bone \u0026amp; Mobility Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports joint comfort, cartilage health, and bone strength\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eHeart \u0026amp; Circulation Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports cardiovascular health and circulation support\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eLiver \u0026amp; Detox Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports detox pathways and metabolic waste clearance\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eMuscle Recovery \u0026amp; Physical Performance\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports muscle recovery, strength, and physical performance\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eAnti-Inflammatory \u0026amp; Comfort Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports inflammation balance and physical comfort\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eHormonal \u0026amp; Anti-Aging Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports healthy aging, hormonal balance, and vitality\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHY THIS APPROACH MAKES SENSE?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM is designed for people who want \u003cstrong\u003etargeted support without overloading the body.\u003c\/strong\u003e By focusing on local transdermal signaling and organ-specific exosome communication, it offers a more controlled and efficient way to support biological balance compared to conventional oral or systemic products.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eDEVELOPED BY CELL TISSUE GROUP\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM reflects Cell Tissue Group’s ongoing work in iPSC technology, exosome science, and organ-specific biological signaling platforms, developed with a focus on safety, precision, and real-world usability.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eZECATRON™ BIOFILM is a wellness support product. It is not intended to diagnose, treat, cure, or prevent any disease. Individual responses may vary.\u003c\/span\u003e\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":43195772043300,"sku":"CT01ZCT08","price":379.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/zecatronbiofilmexosomepatchmainimagesalespage.jpg?v=1769133955"},{"product_id":"exo-nk","title":"EXO-NK™","description":"\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eNext-Generation NK Cell–Derived Exosome Technology\u003c\/strong\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e\u003cstrong\u003eEXO-NK™\u003c\/strong\u003e represents the evolution of immune-focused regenerative science. Developed using \u003cstrong\u003enatural killer (NK) cell-derived exosomes,\u003c\/strong\u003e EXO-NK™ delivers the biological intelligence of NK cells without introducing live cells into the body.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis makes it a powerful, modern option for immune modulation, cellular signaling, and systemic support, designed for those who want advanced biotechnology with a cleaner, more controlled approach.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT MAKES EXO-NK\u003cspan\u003e™\u003c\/span\u003e DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eUnlike conventional immune products that rely on live cell infusion, \u003cstrong\u003eEXO-NK\u003cmeta charset=\"utf-8\"\u003e™ uses purified exosomes released by NK cells.\u003c\/strong\u003e These nanoscale messengers naturally carry proteins, enzymes, microRNA, and immune-signaling molecules that reflect the core function of NK cells: surveillance, communication, and response coordination.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBecause EXO-NK\u003cmeta charset=\"utf-8\"\u003e™ contains \u003cstrong\u003eno living cells\u003c\/strong\u003e, it offers a safer, more stable, and more predictable biological profile while still delivering meaningful cellular signals.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW EXO-NK\u003cspan\u003e™\u003c\/span\u003e WORKS IN THE BODY?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eNK cell exosomes act as \u003cstrong\u003ebiological messengers\u003c\/strong\u003e, interacting with surrounding tissues and immune pathways through paracrine and juxtacrine signaling. Once administered, EXO-NK\u003cmeta charset=\"utf-8\"\u003e™ supports the body by:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eEnhancing immune communication between cells\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eSupporting natural immune surveillance mechanisms\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003ePromoting balanced inflammatory responses\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eSupporting cellular stress response and recovery\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eRather than forcing the body to react, EXO-NK\u003cmeta charset=\"utf-8\"\u003e™ works by guiding and informing, allowing the body’s own systems to respond intelligently.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS OF EXO-NK\u003cspan\u003e™\u003c\/span\u003e\u003c\/strong\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eImmune System Support\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eSupports immune vigilance, resilience, and adaptive response without overstimulation.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eCellular Communication \u0026amp; Signaling\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eDelivers NK-cell–specific molecular signals that help coordinate immune activity at the cellular level.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eNon-Cellular, High-Safety Profile\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eNo live cells, no replication risk, and reduced immunogenic concerns compared to whole-cell therapies.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eEfficient Systemic Delivery\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eExosomes are nanosized and biologically stable, allowing them to interact efficiently with target tissues.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\n\u003cspan\u003e\u003cstrong\u003eReduced Organ Burden\u003c\/strong\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eDesigned to bypass the gastrointestinal tract and first-pass liver metabolism, avoiding the common issue where oral compounds are largely degraded before reaching systemic circulation.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHY EXOSOMES INSTEAD OF LIVE NK CELLS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eLive NK cell therapies can be powerful but come with logistical, regulatory, and biological complexities. EXO-NK\u003cmeta charset=\"utf-8\"\u003e™ offers a more refined alternative:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eNo cell viability dependency\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eNo risk of uncontrolled cell behavior\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eEasier storage and handling\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eMore consistent batch-to-batch performance\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis positions EXO-NK\u003cmeta charset=\"utf-8\"\u003e™ as a next-generation immune signaling platform, rather than a traditional cell therapy.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO EXO-NK\u003cspan\u003e™\u003c\/span\u003e IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eEXO-NK\u003cmeta charset=\"utf-8\"\u003e™ is suitable for individuals seeking advanced immune and cellular support, particularly those interested in:\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eImmune health optimization\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eCellular resilience and recovery\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eAdvanced longevity and wellness strategies\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eAdjunct biological support alongside other regenerative approaches\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eTECHNOLOGY \u0026amp; QUALITY STANDARDS\u003c\/strong\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eDerived from controlled NK cell cultures\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003ePurified exosome isolation process\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eQuality-controlled for consistency and safety\u003c\/span\u003e\u003c\/li\u003e\n\u003cli dir=\"ltr\"\u003e\u003cspan\u003eDeveloped under advanced cell and tissue technology standards\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eFor research and professional use only.\u003cbr\u003e\u003c\/strong\u003e\u003cspan\u003eNot intended to diagnose, treat, cure, or prevent any disease.\u003cbr\u003e\u003c\/span\u003e\u003cspan\u003eThis product is not a pharmaceutical drug and is not registered as such.\u003c\/span\u003e\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":43196226830372,"sku":"CT01EXNK23","price":1199.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/EXO-NK.jpg?v=1769134929"},{"product_id":"genompic","title":"Genompic™","description":"\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eThe Precision Cancer Support Formula\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGenompic™\u003c\/strong\u003e is an advanced precision oncology support solution designed for confirmed cancer cases where a deeper, molecular-level strategy is required.\u003c\/p\u003e\n\u003cp\u003eEvery cancer behaves differently. Even when two patients are diagnosed with the same type of cancer, their underlying molecular activity, gene-expression pattern, tumour behaviour, and treatment response may be very different.\u003c\/p\u003e\n\u003cp\u003eGenompic™ is developed around this principle. Instead of using a general approach, it focuses on identifying selected overactive molecular signals within the patient’s own cancer profile and supporting the regulation of specific gene-expression pathways associated with cancer progression.\u003c\/p\u003e\n\u003cp\u003eThis makes \u003cmeta charset=\"utf-8\"\u003eGenompic™ a highly personalized molecular support option for patients who require a more targeted, data-driven oncology plan.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT GENOMPIC\u003cmeta charset=\"utf-8\"\u003e™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ is a personalized RNA-guided molecular regulation platform.\u003c\/p\u003e\n\u003cp\u003eIt is designed to support the modulation of selected overexpressed messenger RNA signals. Messenger RNA, or mRNA, acts like an instruction message inside the body. It tells cells which proteins to produce.\u003c\/p\u003e\n\u003cp\u003eIn cancer biology, some of these molecular instructions may become overactive. This may lead to the excessive production of proteins that support abnormal cell survival, growth, communication, resistance, or progression.\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ is designed to identify and target selected overactive molecular instructions so that the body’s gene-expression activity can be guided toward a more regulated state.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ helps quiet down selected overactive cancer-related molecular signals.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW \u003cmeta charset=\"utf-8\"\u003eGENOMPIC\u003cmeta charset=\"utf-8\"\u003e™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a patient-specific biological assessment. Through blood-based cancer-cell and molecular profiling, the patient’s cancer-related gene-expression activity is reviewed.\u003c\/p\u003e\n\u003cp\u003eFrom this profile, selected overexpressed molecular signals are identified. These are the signals that may be contributing to abnormal cancer-cell behaviour.\u003c\/p\u003e\n\u003cp\u003eA personalized RNA-guided formulation is then prepared to focus on the most relevant selected target.\u003c\/p\u003e\n\u003cp\u003eOnce administered under professional supervision, the formulation is designed to interact with the selected messenger RNA signal and support the reduction of abnormal protein-signalling activity.\u003c\/p\u003e\n\u003cp\u003eThis approach works at the molecular instruction level.\u003c\/p\u003e\n\u003cp\u003eInstead of only asking:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“What type of cancer does the patient have?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ goes deeper and asks:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“Which molecular signal is driving the activity in this individual patient?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT MAKES \u003cmeta charset=\"utf-8\"\u003eGENOMPIC\u003cmeta charset=\"utf-8\"\u003e™ DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized to Each Patient\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cmeta charset=\"utf-8\"\u003eGenompic™ is not a standard formula. It is developed based on the patient’s own cancer-related biological profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecularly Targeted\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt focuses on selected overexpressed gene signals rather than applying a broad, generalized approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRNA-Guided Technology\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt uses an RNA-guided regulatory concept inspired by natural gene-expression control pathways.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDesigned for Precision Oncology\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt supports a more individualized oncology strategy by helping identify and regulate specific molecular activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Doctor-Led Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cmeta charset=\"utf-8\"\u003eGenompic™ is intended to be used as part of a professional oncology support plan, not as a standalone decision or self-directed product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Molecular-Level Precision\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps guide oncology support based on selected gene-expression signals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTargets Overactive Cancer-Related Pathways\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eFocuses on molecular signals that may be associated with abnormal cancer-cell activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalizes the Support Strategy\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAllows the approach to be tailored according to the patient’s own cancer-cell profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Planning Discussions\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eProvides additional molecular insight that may help doctors evaluate suitable next steps.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplements Advanced Oncology Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be considered alongside other professional oncology assessments and ongoing patient monitoring.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eGENOMPIC\u003cmeta charset=\"utf-8\"\u003e™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ is designed for confirmed cancer patients who require a personalized molecular support strategy.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003ehave confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003erequire deeper molecular insight\u003c\/li\u003e\n\u003cli\u003eare exploring precision oncology support\u003c\/li\u003e\n\u003cli\u003eneed cancer-cell profiling before planning\u003c\/li\u003e\n\u003cli\u003eare undergoing doctor-led cancer management\u003c\/li\u003e\n\u003cli\u003erequire a personalized supportive approach beyond general wellness care\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eSuitability depends on professional review of:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003ecancer type\u003c\/li\u003e\n\u003cli\u003etumour burden\u003c\/li\u003e\n\u003cli\u003ecurrent treatment status\u003c\/li\u003e\n\u003cli\u003eblood-based cancer-cell findings\u003c\/li\u003e\n\u003cli\u003eimaging results\u003c\/li\u003e\n\u003cli\u003emedical history\u003c\/li\u003e\n\u003cli\u003eorgan function\u003c\/li\u003e\n\u003cli\u003eoverall clinical condition\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cmeta charset=\"utf-8\"\u003eGenompic™ is intended for professional and doctor-supervised use only. It is not intended to diagnose, treat, cure, or prevent any disease as a standalone product. Suitability must be determined by qualified medical professionals based on the patient’s clinical condition, cancer profile, investigation results, and overall treatment plan.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44190794809380,"sku":"CTGENO0073","price":11888.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMGenompic01_cb59723b-16da-4eda-b534-89c9456bf51a.jpg?v=1779183621"},{"product_id":"novara-t","title":"Novara-T™","description":"\u003cp\u003e\u003cstrong\u003ePersonalized Cancer Support System\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNovara-T™\u003c\/strong\u003e is an advanced precision oncology support solution designed for confirmed cancer cases where personalized immune-recognition planning may be required.\u003c\/p\u003e\n\u003cp\u003eCancer cells are not always easily recognized by the immune system. Over time, they may develop ways to hide, change their surface signals, or reduce immune visibility. This can make it harder for the body’s natural defense system to identify abnormal cells effectively.\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is developed around a personalized tumor-intelligence concept. It focuses on using patient-specific tumor-associated biological information to support immune recognition, allowing a more tailored and targeted oncology support strategy.\u003c\/p\u003e\n\u003cp\u003eThis makes Novara-T™ suitable for patients who require a more individualized immune-focused approach as part of doctor-led cancer management.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT NOVARA-T™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is a \u003cstrong\u003epersonalized tumor antigen intelligence platform.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is designed to support the immune system by introducing selected tumor-associated biological information derived from the patient’s own cancer profile.\u003c\/p\u003e\n\u003cp\u003eIn cancer biology, tumor cells may carry unique signatures that differentiate them from normal healthy cells. These signatures may include tumor-related surface patterns, structural components, protein fragments, cellular signals, and other biological markers linked to abnormal cancer-cell behavior.\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is designed to help create a clearer immune reference profile so the body’s defense system can better recognize tumor-associated signals.\u003c\/p\u003e\n\u003cp\u003eIn simple terms:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNovara-T™ helps the immune system better understand what it needs to recognize.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a patient-specific cancer-cell and immune assessment.\u003c\/p\u003e\n\u003cp\u003eThrough advanced profiling, the patient’s tumor-associated biological information is reviewed. This helps identify relevant antigenic patterns and immune-related signals that may be useful for personalized planning.\u003c\/p\u003e\n\u003cp\u003eOnce the patient’s cancer profile and immune readiness are assessed, Novara-T™ is prepared as a personalized immune-recognition support product.\u003c\/p\u003e\n\u003cp\u003eThe goal is to provide the immune system with a more specific tumor-associated reference, helping support immune awareness and recognition.\u003c\/p\u003e\n\u003cp\u003eInstead of only asking:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“What type of cancer does the patient have?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ goes further and asks:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e“What unique tumor signals does this patient’s immune system need to recognize?”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT MAKES \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized to Each Patient\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is developed based on the patient’s own tumor-associated biological profile. It is not a standard, one-size-fits-all product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTumor-Antigen Intelligence\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt focuses on tumor-associated recognition signals rather than general immune stimulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune Recognition Support\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is designed to support the immune system’s ability to identify cancer-related biological patterns more clearly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-Live-Cell Concept\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is not a live-cell infusion product. It is not NK cell therapy and not CAR-T therapy. It works through a tumor-antigen intelligence concept that supports immune recognition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDesigned for Precision Oncology\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ supports a more individualized oncology strategy by combining cancer-cell information with immune-status review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Doctor-Led Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNovara-T™ is intended to be used as part of a professional oncology support plan, under the supervision of qualified healthcare personnel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Immune Recognition\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps provide tumor-associated information that may support immune awareness.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGuides Immune-Focused Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eUseful when doctors want to explore whether immune-recognition support is suitable for the patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUses Patient-Specific Tumor Intelligence\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDeveloped based on the patient’s own cancer-related biological profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplements Advanced Cancer-Cell Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be considered alongside blood-based cancer-cell assessment and immune-status profiling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports a More Targeted Support Strategy\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps move beyond generic immune support toward a more personalized, data-guided approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eNOVARA-T™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is designed for \u003cstrong\u003econfirmed cancer patients\u003c\/strong\u003e who may require personalized immune-recognition support as part of a professional oncology plan.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003erequire deeper cancer-cell profiling before planning\u003c\/li\u003e\n\u003cli\u003eare exploring personalized oncology support\u003c\/li\u003e\n\u003cli\u003emay benefit from immune-recognition assessment\u003c\/li\u003e\n\u003cli\u003erequire doctor-led immune-focused planning\u003c\/li\u003e\n\u003cli\u003eare undergoing advanced cancer management review\u003c\/li\u003e\n\u003cli\u003eneed a more individualized strategy beyond general wellness care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSuitability depends on professional review of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer type\u003c\/li\u003e\n\u003cli\u003edisease stage\u003c\/li\u003e\n\u003cli\u003etumor burden\u003c\/li\u003e\n\u003cli\u003eimmune status\u003c\/li\u003e\n\u003cli\u003ecurrent treatment status\u003c\/li\u003e\n\u003cli\u003eblood-based cancer-cell findings\u003c\/li\u003e\n\u003cli\u003eimaging results\u003c\/li\u003e\n\u003cli\u003emedical history\u003c\/li\u003e\n\u003cli\u003eorgan function\u003c\/li\u003e\n\u003cli\u003eoverall clinical condition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNovara-T™ may not be suitable for every patient, especially where immune function is severely compromised. A professional medical review is required before use.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eRECOMMENDED PRE-ASSESSMENT\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBefore Novara-T™ can be considered, patients should undergo appropriate professional evaluation to assess:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer-cell profile\u003c\/li\u003e\n\u003cli\u003etumor-associated biological signals\u003c\/li\u003e\n\u003cli\u003eimmune activation or suppression status\u003c\/li\u003e\n\u003cli\u003ecurrent treatment history\u003c\/li\u003e\n\u003cli\u003esuitability for immune-recognition support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis helps ensure that Novara-T™ is used only when the patient’s condition and immune status are suitable.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNovara-T™ is intended for professional and doctor-supervised use only. It is not chemotherapy, radiation therapy, NK cell therapy, or CAR-T therapy. It is not intended to diagnose, treat, cure, or prevent any disease as a standalone product.\u003c\/p\u003e\n\u003cp\u003eSuitability must be determined by qualified medical professionals based on the patient’s clinical condition, cancer profile, immune status, investigation results, and overall treatment plan.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191348916260,"sku":"CTNOVT0074","price":39999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMNovara-T01_e18a6724-9c0c-416b-b2ac-025aee670920.jpg?v=1779183599"},{"product_id":"tumotest","title":"TumoTest™ - Circulating Tumor Cell Test","description":"\u003cp\u003e\u003cstrong\u003eTumoTest™\u003c\/strong\u003e is an advanced blood-based circulating tumor cell test designed for confirmed cancer patients who require deeper cancer monitoring, treatment-response tracking, and personalized oncology planning.\u003c\/p\u003e\n\u003cp\u003eCancer is not only defined by the tumour seen on imaging. In many cases, cancer-related cells may circulate in the bloodstream and provide important information about disease activity, tumour behaviour, aggressiveness, and possible response to ongoing treatment.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is developed to help doctors better understand what is happening beyond conventional scans and tumour markers by analysing circulating tumor cells, also known as CTCs, from a blood sample.\u003c\/p\u003e\n\u003cp\u003eThis makes TumoTest™ a valuable monitoring tool for patients undergoing doctor-led cancer management.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT \u003cmeta charset=\"utf-8\"\u003eTUMOTEST™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is a \u003cstrong\u003eCirculating Tumor Cell Test.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCirculating Tumor Cells, or CTCs, are cancer-related cells that may detach from a primary tumour or metastatic site and enter the bloodstream.\u003c\/p\u003e\n\u003cp\u003eBy analysing these cells, TumoTest™ helps provide additional insight into:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer-cell presence in circulation\u003c\/li\u003e\n\u003cli\u003ecancer-cell characteristics\u003c\/li\u003e\n\u003cli\u003etumour behaviour\u003c\/li\u003e\n\u003cli\u003edisease activity\u003c\/li\u003e\n\u003cli\u003etreatment response\u003c\/li\u003e\n\u003cli\u003epossible aggressiveness\u003c\/li\u003e\n\u003cli\u003emetastatic potential\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eTumoTest™ helps detect and study cancer-related cells circulating in the blood.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is not a general cancer screening test for healthy individuals. It is mainly designed for patients with \u003cstrong\u003econfirmed cancer diagnosis\u003c\/strong\u003e or patients under doctor-led oncology monitoring.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW TUMOTEST™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a blood sample.\u003c\/p\u003e\n\u003cp\u003eThe sample is analysed to identify and evaluate circulating tumor cells. These cells may carry useful information about the patient’s current cancer status.\u003c\/p\u003e\n\u003cp\u003eThrough CTC analysis, doctors can obtain a clearer picture of how the cancer may be behaving at that point in time.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may help evaluate:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ewhether circulating tumor cells are present\u003c\/li\u003e\n\u003cli\u003ehow many CTCs are detected\u003c\/li\u003e\n\u003cli\u003ewhether the CTC level is changing over time\u003c\/li\u003e\n\u003cli\u003ewhether cancer-cell characteristics suggest higher or lower activity\u003c\/li\u003e\n\u003cli\u003ewhether treatment appears to be reducing cancer-cell burden\u003c\/li\u003e\n\u003cli\u003ewhether further treatment planning should be considered\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis allows cancer monitoring to become more dynamic, rather than depending only on imaging or routine tumour markers.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHY CIRCULATING TUMOR CELLS MATTER?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCancer cells may not remain only in one location.\u003c\/p\u003e\n\u003cp\u003eSome cancer cells can enter the bloodstream and travel through the body. These circulating tumor cells may provide important biological information about cancer progression, treatment response, and metastatic behaviour.\u003c\/p\u003e\n\u003cp\u003eMonitoring CTCs can help doctors understand whether the cancer appears to be:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eresponding to treatment\u003c\/li\u003e\n\u003cli\u003eremaining active\u003c\/li\u003e\n\u003cli\u003echanging in behaviour\u003c\/li\u003e\n\u003cli\u003eshowing signs of higher aggressiveness\u003c\/li\u003e\n\u003cli\u003erequiring closer monitoring\u003c\/li\u003e\n\u003cli\u003eneeding further investigation or treatment adjustment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTumoTest™ supports this by helping provide a blood-based view of cancer-related cellular activity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES TUMOTEST™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood-Based Cancer Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ uses a blood sample to study circulating tumor cells, offering an additional layer of information beyond conventional tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocuses on Confirmed Cancer Cases\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ is designed for patients with confirmed cancer diagnosis, especially those who need monitoring during or after treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTracks Cancer-Cell Activity\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eInstead of only looking at tumour size, TumoTest™ helps review cancer-cell activity in circulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Response Review\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eA reduction in CTC number or improvement in cancer-cell characteristics may help support the assessment of treatment response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Biological Insight\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eTumoTest™ may provide information related to cancer-cell behaviour, including aggressiveness, stemness, and metastatic potential.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help doctors decide whether the patient requires continued monitoring, additional investigation, or further treatment planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitors Circulating Tumor Cells\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps detect and evaluate cancer-related cells circulating in the bloodstream.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Response Tracking\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be used to compare changes before, during, or after treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Additional Insight Beyond Tumour Markers\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eGives doctors another layer of biological information beyond routine blood tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Understand Cancer Behaviour\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay provide information related to tumour aggressiveness, cancer-cell characteristics, and metastatic activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Ongoing Cancer Management\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSupports monitoring in patients undergoing chemotherapy, immunotherapy, targeted therapy, integrative oncology support, or post-treatment follow-up.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Advanced Personalized Care\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be used as part of a broader precision oncology workflow to guide doctor-led decision-making.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO TUMOTEST™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is designed for \u003cstrong\u003econfirmed cancer patients\u003c\/strong\u003e who need advanced monitoring and deeper cancer-cell insight.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eare currently undergoing cancer treatment\u003c\/li\u003e\n\u003cli\u003ehave completed treatment and require monitoring\u003c\/li\u003e\n\u003cli\u003eneed treatment response assessment\u003c\/li\u003e\n\u003cli\u003ehave unclear tumour marker results\u003c\/li\u003e\n\u003cli\u003ewant deeper cancer-cell activity tracking\u003c\/li\u003e\n\u003cli\u003eare being evaluated for personalized oncology support\u003c\/li\u003e\n\u003cli\u003erequire additional information before advanced treatment planning\u003c\/li\u003e\n\u003cli\u003eneed monitoring of disease activity over time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTumoTest™ may be useful in doctor-led cancer management where CTC information can support clearer case understanding.\u003c\/p\u003e\n\u003cp\u003eWHEN TUMOTEST™ MAY BE RECOMMENDED?\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may be considered:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ebefore starting a new treatment plan\u003c\/li\u003e\n\u003cli\u003eduring ongoing cancer treatment\u003c\/li\u003e\n\u003cli\u003eafter chemotherapy, immunotherapy, targeted therapy, or other oncology care\u003c\/li\u003e\n\u003cli\u003ewhen tumour markers are unclear or insufficient\u003c\/li\u003e\n\u003cli\u003ewhen imaging results need additional biological context\u003c\/li\u003e\n\u003cli\u003eduring follow-up monitoring\u003c\/li\u003e\n\u003cli\u003ebefore considering advanced personalized oncology support\u003c\/li\u003e\n\u003cli\u003ewhen doctors need blood-based cancer-cell information\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor patients on active chemotherapy, blood draw timing should be planned carefully under professional guidance, usually during an appropriate gap between treatment cycles.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ may provide information such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003epresence of circulating tumor cells\u003c\/li\u003e\n\u003cli\u003eCTC count\u003c\/li\u003e\n\u003cli\u003ecancer-cell characteristics\u003c\/li\u003e\n\u003cli\u003etumour activity indicators\u003c\/li\u003e\n\u003cli\u003echanges compared to previous results\u003c\/li\u003e\n\u003cli\u003epossible treatment-response pattern\u003c\/li\u003e\n\u003cli\u003ebiological signs linked to cancer aggressiveness\u003c\/li\u003e\n\u003cli\u003eindicators that may support further oncology planning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA falling CTC number or improvement in cancer-cell characteristics may help support the impression that a treatment approach is working. However, interpretation must always be done by a qualified medical professional together with imaging, tumour markers, symptoms, and clinical findings.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW TUMOTEST™ SUPPORTS PERSONALIZED ONCOLOGY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEvery cancer behaves differently.\u003c\/p\u003e\n\u003cp\u003eTwo patients with the same diagnosis may have different circulating tumor cell profiles, different response patterns, and different levels of cancer-cell activity.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ helps doctors move beyond a one-size-fits-all view by providing blood-based information on the patient’s actual cancer-cell behaviour.\u003c\/p\u003e\n\u003cp\u003eThis may support more informed decisions on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003emonitoring frequency\u003c\/li\u003e\n\u003cli\u003etreatment response\u003c\/li\u003e\n\u003cli\u003efurther investigation\u003c\/li\u003e\n\u003cli\u003esuitability for advanced oncology support\u003c\/li\u003e\n\u003cli\u003efollow-up planning\u003c\/li\u003e\n\u003cli\u003epersonalized treatment discussion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eSAMPLE \u0026amp; PROFESSIONAL WORKFLOW\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is performed through a professional blood collection process.\u003c\/p\u003e\n\u003cp\u003eThe general workflow may include:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eDoctor consultation and case review\u003c\/li\u003e\n\u003cli\u003eBlood sample collection\u003c\/li\u003e\n\u003cli\u003eSample handling and shipment according to protocol\u003c\/li\u003e\n\u003cli\u003eLaboratory analysis of circulating tumor cells\u003c\/li\u003e\n\u003cli\u003eReport generation\u003c\/li\u003e\n\u003cli\u003eDoctor-led interpretation\u003c\/li\u003e\n\u003cli\u003eFollow-up planning based on the patient’s overall condition\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe result should not be interpreted in isolation. It should be reviewed together with the patient’s diagnosis, imaging reports, tumour markers, current treatment, medications, symptoms, and overall clinical status.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is a circulating tumor cell test intended for professional use and doctor-led interpretation.\u003c\/p\u003e\n\u003cp\u003eIt is not intended to diagnose cancer as a standalone test, treat cancer, cure cancer, or prevent cancer. Results must be interpreted by qualified medical professionals and reviewed together with the patient’s clinical history, imaging, laboratory findings, treatment status, and overall medical condition.\u003c\/p\u003e\n\u003cp\u003eTumoTest™ is designed to support cancer monitoring and personalized oncology planning, not replace specialist oncology consultation or standard medical care.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191440961572,"sku":"CTTUMO0075","price":4999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMTumoTest01_6f2e1f3a-9a64-456c-aade-00c8407d6f7f.jpg?v=1779183574"},{"product_id":"immotest-i","title":"ImmoTest-I™","description":"\u003cp\u003e\u003cstrong\u003eAdvanced Body Defense Mapping Test\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-I™\u003c\/strong\u003e is an advanced blood-based immune profiling test designed to assess immune activation, immune suppression, and immune readiness in cancer-related clinical planning.\u003c\/p\u003e\n\u003cp\u003eThe immune system plays an important role in cancer surveillance, treatment response, and overall patient resilience. However, not every patient has the same immune condition. Some patients may show strong immune activation, while others may show signs of immune suppression, immune exhaustion, chronic inflammation, or immune imbalance.\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ helps provide a clearer picture of the patient’s immune status, allowing doctors to better understand whether the immune system is ready, suppressed, or imbalanced before planning immune-related oncology support.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT IMMOTEST-I™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is an immune profiling test that evaluates selected immune markers, cytokines, and immune-cell activity patterns from a blood sample.\u003c\/p\u003e\n\u003cp\u003eIt is designed to help medical professionals understand the patient’s immune condition, especially in cases where immune-based support or precision oncology planning may be considered.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-I™ helps map how the immune system is behaving.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt provides information about immune activation and immune suppression, which may help support professional decision-making.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW IMMOTEST-I™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ analyses the immune system from multiple angles.\u003c\/p\u003e\n\u003cp\u003eThe test may evaluate immune-related markers linked to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eB-cell activity\u003c\/li\u003e\n\u003cli\u003eT-cell activity\u003c\/li\u003e\n\u003cli\u003ecytotoxic immune response\u003c\/li\u003e\n\u003cli\u003ehelper immune response\u003c\/li\u003e\n\u003cli\u003eimmune suppression\u003c\/li\u003e\n\u003cli\u003eregulatory immune pathways\u003c\/li\u003e\n\u003cli\u003eantigen-presenting cell activity\u003c\/li\u003e\n\u003cli\u003einflammatory and anti-inflammatory signalling\u003c\/li\u003e\n\u003cli\u003eimmune readiness\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBased on the sample report, the laboratory process includes serum isolation from whole blood, ELISA testing for immune activation\/suppression cytokines, and flow cytometry for selected immune-cell markers.\u003c\/p\u003e\n\u003cp\u003eBy reviewing these markers together, ImmoTest-I™ provides a structured immune profile that may help doctors assess whether the patient’s immune system is activated, suppressed, or imbalanced.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES IMMOTEST-I™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune-Readiness Focused\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-I™ helps assess whether the patient’s immune system may be suitable for immune-related oncology support planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActivation and Suppression Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt reviews both immune activation and immune suppression, instead of only giving a general “immune strength” impression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help doctors decide whether immune-related support is appropriate, needs to be delayed, or requires further evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful Before Immune-Based Support\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-I™ may be useful before considering approaches that depend on immune recognition, immune response, or immune readiness.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Decision-Support Tool\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt is designed to support medical interpretation and clinical planning, not to replace specialist consultation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaps Immune Status\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eProvides a structured overview of immune activation, suppression, and immune balance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Suitability Assessment\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps doctors assess whether immune-related support may be suitable for the patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Case Understanding\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eGives additional insight into the patient’s immune condition beyond routine blood tests.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps align the support strategy with the patient’s actual immune profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Identify Immune Suppression\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay help detect patterns of immune down-regulation or immune imbalance that require professional attention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Ongoing Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay support immune-status review during cancer management, follow-up, or advanced oncology planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eIMMOTEST-I™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is designed for patients who require deeper immune assessment as part of professional oncology planning.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eare being considered for immune-related support\u003c\/li\u003e\n\u003cli\u003erequire immune-readiness assessment\u003c\/li\u003e\n\u003cli\u003ehave complex cancer cases\u003c\/li\u003e\n\u003cli\u003eare undergoing advanced oncology planning\u003c\/li\u003e\n\u003cli\u003eneed immune activation or suppression profiling\u003c\/li\u003e\n\u003cli\u003erequire better understanding of immune status\u003c\/li\u003e\n\u003cli\u003emay be considered for tumour-recognition or immune-support strategies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSuitability and interpretation should always be guided by qualified healthcare professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHEN IMMOTEST-I™ MAY BE RECOMMENDED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ may be considered before:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eimmune-related oncology support\u003c\/li\u003e\n\u003cli\u003epersonalised cancer support planning\u003c\/li\u003e\n\u003cli\u003etumour-recognition support strategies\u003c\/li\u003e\n\u003cli\u003eadvanced oncology monitoring\u003c\/li\u003e\n\u003cli\u003ecombination support programs\u003c\/li\u003e\n\u003cli\u003edoctor-led cancer management review\u003c\/li\u003e\n\u003cli\u003eimmune-readiness evaluation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt may also be used when doctors need a clearer understanding of whether the patient’s immune system is activated, suppressed, or imbalanced.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ may provide information related to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eimmune activation\u003c\/li\u003e\n\u003cli\u003eimmune suppression\u003c\/li\u003e\n\u003cli\u003ecytokine activity\u003c\/li\u003e\n\u003cli\u003eT-cell activity\u003c\/li\u003e\n\u003cli\u003eB-cell activity\u003c\/li\u003e\n\u003cli\u003ecytotoxic immune response\u003c\/li\u003e\n\u003cli\u003ehelper immune response\u003c\/li\u003e\n\u003cli\u003eregulatory immune activity\u003c\/li\u003e\n\u003cli\u003eantigen-presenting cell function\u003c\/li\u003e\n\u003cli\u003eimmune balance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe sample report includes markers such as CD19, CD20, CD28, CD62L, IFN-γ, IL-4, IL-6, IL-2, TNF-α, CD25, CTLA4, CD80, and CD86. These are immune-related markers used to support immune activation\/suppression profiling.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW RESULTS SHOULD BE USED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ results should be interpreted by qualified medical professionals.\u003c\/p\u003e\n\u003cp\u003eThe result should be reviewed together with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer diagnosis\u003c\/li\u003e\n\u003cli\u003eimaging reports\u003c\/li\u003e\n\u003cli\u003eblood investigations\u003c\/li\u003e\n\u003cli\u003etreatment history\u003c\/li\u003e\n\u003cli\u003ecurrent medications\u003c\/li\u003e\n\u003cli\u003eimmune-related conditions\u003c\/li\u003e\n\u003cli\u003eperformance status\u003c\/li\u003e\n\u003cli\u003esymptoms\u003c\/li\u003e\n\u003cli\u003eoverall patient condition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe test does not provide a treatment decision by itself. It supports better clinical understanding and professional case planning.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is an immune profiling test. It is not intended to diagnose cancer, treat cancer, cure cancer, or prevent cancer.\u003c\/p\u003e\n\u003cp\u003eResults must be interpreted by qualified medical professionals and reviewed together with the patient’s clinical history, imaging, laboratory findings, treatment status, and overall medical condition.\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is designed to support immune-status assessment and personalized oncology planning, not to replace oncology consultation or standard medical care.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191475269668,"sku":"CTTIMO10076","price":5999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMImmoTest-I01.jpg?v=1779183366"},{"product_id":"immotest-ii","title":"ImmoTest-II™","description":"\u003cp\u003e\u003cstrong\u003eEarly Cancer Signal Screening\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-II™ \u003c\/strong\u003eis an advanced blood-based screening test designed to detect early biological signals that may be associated with cancer-related activity in the body.\u003c\/p\u003e\n\u003cp\u003eMany conventional cancer screening methods focus on visible tumours, imaging findings, or selected tumour markers. While these tools are important, they may not always capture early biological changes happening at the cellular and molecular level.\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ is designed to provide a deeper layer of insight by analysing the body’s biological response patterns and selected gene-expression signals. This helps medical professionals identify whether further cancer-related investigation may be required.\u003c\/p\u003e\n\u003cp\u003eIt is suitable for individuals who want a more proactive, advanced, and preventive approach to cancer-related screening.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT IMMOTEST-II™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ is an advanced cancer signal screening test performed using a blood sample.\u003c\/p\u003e\n\u003cp\u003eIt is designed to study how the body responds to cancer-related biological activity by analysing selected cellular and molecular patterns.\u003c\/p\u003e\n\u003cp\u003eRather than only checking one tumour marker, ImmoTest-II™ looks at a broader biological picture. It reviews selected gene-expression activities and response patterns that may indicate whether the body is showing early warning signals that require further medical attention.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-II™ helps detect early cancer-related signals in the body before a clearer clinical picture may appear.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is not a standalone cancer diagnosis. It is a screening and investigation-support test that helps doctors decide whether further medical evaluation, imaging, or specialist review may be needed.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW IMMOTEST-II™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process starts with a blood sample.\u003c\/p\u003e\n\u003cp\u003eFrom the sample, selected blood components are analysed to study cellular response and gene-expression activity. These biological signals are then reviewed to identify whether the pattern appears normal or suggests possible cancer-related activity.\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ may assess pathways related to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCell growth and regulation\u003c\/li\u003e\n\u003cli\u003eAbnormal cellular signalling\u003c\/li\u003e\n\u003cli\u003eInflammation-related response\u003c\/li\u003e\n\u003cli\u003eCell repair mechanisms\u003c\/li\u003e\n\u003cli\u003eCell survival pathways\u003c\/li\u003e\n\u003cli\u003eBlood vessel formation activity\u003c\/li\u003e\n\u003cli\u003eStress-response patterns\u003c\/li\u003e\n\u003cli\u003eCancer-related molecular activity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe goal is to identify whether the body is showing a concerning biological response that should be investigated further.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES IMMOTEST-II™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEarly Signal Screening\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-II™ is designed to identify early biological patterns that may require further cancer-related investigation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGoes Beyond Routine Tumour Markers\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt does not depend only on conventional tumour marker readings. It reviews broader cellular and molecular response patterns.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood-Based Testing\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe test is performed using a blood sample, making it convenient for advanced screening and preventive health programs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Preventive Health Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-II™ can be included as part of executive screening, longevity programs, and proactive health monitoring.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGuides Next-Step Investigation\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help doctors decide whether imaging, specialist consultation, repeat testing, or further diagnostic workup is needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSuitable for High-Risk Individuals\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt may be useful for individuals with family history of cancer, unexplained health concerns, or those seeking deeper preventive screening.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetects Early Biological Signals\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps identify whether the body is showing cancer-related biological patterns that may require medical attention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Insight Than Basic Screening\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eGoes beyond routine blood tests and isolated tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Early Investigation\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps guide whether further medical evaluation, imaging, or specialist review should be considered.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Preventive Health Programs\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be incorporated into executive wellness, longevity, and advanced health screening packages.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Doctors Make Better Decisions\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eProvides additional biological information to support professional interpretation and next-step planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay help create a more tailored screening and monitoring approach based on the individual’s biological profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eIMMOTEST-II™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ is designed for individuals who want a more advanced cancer-related screening approach.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for those who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eWant deeper cancer-related screening\u003c\/li\u003e\n\u003cli\u003eHave a family history of cancer\u003c\/li\u003e\n\u003cli\u003eAre undergoing executive health screening\u003c\/li\u003e\n\u003cli\u003eWant proactive preventive health monitoring\u003c\/li\u003e\n\u003cli\u003eHave unexplained symptoms that require further investigation\u003c\/li\u003e\n\u003cli\u003eWant more information beyond routine tumour markers\u003c\/li\u003e\n\u003cli\u003eAre advised by a doctor to undergo deeper biological screening\u003c\/li\u003e\n\u003cli\u003eAre enrolled in longevity or premium wellness programs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eImmoTest-II™ is suitable for people who want early biological insight, but it must always be interpreted by qualified healthcare professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHEN IMMOTEST-II™ MAY BE RECOMMENDED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ may be considered as part of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnnual advanced health screening\u003c\/li\u003e\n\u003cli\u003eExecutive health screening\u003c\/li\u003e\n\u003cli\u003ePreventive cancer-related screening\u003c\/li\u003e\n\u003cli\u003eFamily-history-based monitoring\u003c\/li\u003e\n\u003cli\u003eLongevity and wellness programs\u003c\/li\u003e\n\u003cli\u003eDoctor-led investigation planning\u003c\/li\u003e\n\u003cli\u003ePremium health assessment packages\u003c\/li\u003e\n\u003cli\u003eFollow-up screening where deeper biological insight is needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt may also be recommended when routine screening results are unclear, or when the doctor wants an additional layer of biological information before deciding the next step.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ may indicate whether the body is showing a normal or concerning biological response pattern.\u003c\/p\u003e\n\u003cp\u003eA concerning result does not automatically mean cancer is confirmed.\u003c\/p\u003e\n\u003cp\u003eIt may suggest that further investigations should be considered, such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eImaging\u003c\/li\u003e\n\u003cli\u003eSpecialist consultation\u003c\/li\u003e\n\u003cli\u003eAdditional blood tests\u003c\/li\u003e\n\u003cli\u003eOrgan-specific screening\u003c\/li\u003e\n\u003cli\u003eRepeat testing\u003c\/li\u003e\n\u003cli\u003eCloser medical monitoring\u003c\/li\u003e\n\u003cli\u003eFurther diagnostic workup\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe result should always be reviewed together with the patient’s medical history, symptoms, physical examination, imaging, laboratory findings, and doctor’s assessment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW IMMOTEST-II™ SUPPORTS EARLY INVESTIGATION?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEarly cancer-related changes may not always be visible through imaging or obvious symptoms.\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ supports early investigation by looking at biological response patterns that may appear before a clear diagnosis is made.\u003c\/p\u003e\n\u003cp\u003eThis allows the doctor to take a more proactive approach when something appears unusual.\u003c\/p\u003e\n\u003cp\u003eThe test does not replace standard screening, imaging, or specialist assessment. Instead, it adds another layer of insight to help guide a more complete evaluation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSAMPLE AND PROFESSIONAL WORKFLOW\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ is performed through a professional blood collection process.\u003c\/p\u003e\n\u003cp\u003eThe general workflow may include:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eDoctor consultation and suitability review\u003c\/li\u003e\n\u003cli\u003eBlood sample collection\u003c\/li\u003e\n\u003cli\u003eLaboratory analysis\u003c\/li\u003e\n\u003cli\u003eBiological response and gene-expression review\u003c\/li\u003e\n\u003cli\u003eReport generation\u003c\/li\u003e\n\u003cli\u003eDoctor-led interpretation\u003c\/li\u003e\n\u003cli\u003eRecommendation for further investigation, if required\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe test result should not be interpreted alone. It should be assessed together with the patient’s overall clinical condition and relevant medical findings.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-II™ is a screening and investigation-support test. It is not intended to independently diagnose cancer, treat cancer, cure cancer, or prevent cancer.\u003c\/p\u003e\n\u003cp\u003eA concerning result does not confirm cancer. Further medical evaluation may be required.\u003c\/p\u003e\n\u003cp\u003eResults must be interpreted by qualified medical professionals and reviewed together with the patient’s symptoms, medical history, imaging, laboratory findings, and overall clinical condition.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191520522276,"sku":"CTTIMO20077","price":4999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMImmoTest-II01.jpg?v=1779184935"},{"product_id":"naturamatch","title":"NaturaMatch™","description":"\u003cp\u003e\u003cstrong\u003eNatural Compound Response Profiling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNaturaMatch™\u003c\/strong\u003e is an advanced personalized cancer-cell response profiling test designed to evaluate how an individual patient’s cancer cells respond to selected natural substances and plant-derived compounds.\u003c\/p\u003e\n\u003cp\u003eCancer biology can vary significantly between individuals. A natural compound that appears relevant for one patient may show a very different response in another. NaturaMatch™ provides laboratory-based information using the patient’s own circulating tumour cells to help healthcare professionals make more informed decisions when considering natural compounds as part of a professionally supervised integrative oncology plan.\u003c\/p\u003e\n\u003cp\u003eRather than selecting supplements based only on general recommendations, NaturaMatch™ provides a more personalized approach based on the biological response of the individual patient’s cancer cells.\u003c\/p\u003e\n\u003cp\u003eTwo levels of testing are available:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan style=\"font-family: -apple-system, BlinkMacSystemFont, 'San Francisco', 'Segoe UI', Roboto, 'Helvetica Neue', sans-serif; font-size: 0.875rem;\"\u003eNaturaMatch™ Standard: \u003c\/span\u003e\u003c\/strong\u003eNatural Compound Response Profiling\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNaturaMatch Molecular\u003cmeta charset=\"utf-8\"\u003e™ Advanced: \u003c\/strong\u003eNatural Compound \u0026amp; Molecular Profiling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT NATURAMATCH™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNaturaMatch™ is a blood-based cancer-cell response profiling test designed for individuals with an established cancer diagnosis.\u003c\/p\u003e\n\u003cp\u003eThe test isolates circulating tumour cells, also known as CTCs, from the patient's blood and evaluates how these cells respond when exposed to a broad panel of selected natural substances and plant extracts.\u003c\/p\u003e\n\u003cp\u003eMore than 50 selected natural compounds may be evaluated across different functional categories, including compounds studied for direct cellular effects, immune-related activity and cellular signalling pathways.\u003c\/p\u003e\n\u003cp\u003eThe test also provides information on the patient's circulating tumour cell count.\u003c\/p\u003e\n\u003cp\u003eThe results are intended to support professional treatment planning and should not be interpreted as a guarantee that a particular supplement or compound will produce the same effect inside the body.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW NATURAMATCH™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a professionally collected blood sample.\u003c\/p\u003e\n\u003cp\u003eCirculating tumour cells are isolated from the sample and used for laboratory response testing.\u003c\/p\u003e\n\u003cp\u003eSelected natural substances and plant extracts are then evaluated against the patient's cancer cells to observe how the cells respond under controlled laboratory conditions.\u003c\/p\u003e\n\u003cp\u003eThe general process includes:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eDoctor consultation and suitability assessment\u003c\/li\u003e\n\u003cli\u003eProfessional blood sample collection\u003c\/li\u003e\n\u003cli\u003eIsolation of circulating tumour cells\u003c\/li\u003e\n\u003cli\u003eLaboratory testing against selected natural compounds\u003c\/li\u003e\n\u003cli\u003eComparative response analysis\u003c\/li\u003e\n\u003cli\u003eReport generation\u003c\/li\u003e\n\u003cli\u003eDoctor-led interpretation\u003c\/li\u003e\n\u003cli\u003ePersonalized integrative oncology planning\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eFor selected central nervous system primary tumours, an appropriate tissue sample may be required instead of a standard peripheral blood sample.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCHOOSE YOUR NATURAMATCH™ VARIANT\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNaturaMatch™ Standard\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDesigned for patients who primarily want to understand which \u003cstrong\u003eselected natural substances and plant extracts demonstrate stronger or weaker responses against their cancer cells.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe Standard profile includes:\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCirculating tumour cell assessment\u003c\/li\u003e\n\u003cli\u003eResponse profiling against more than 50 selected natural substances and plant extracts\u003c\/li\u003e\n\u003cli\u003eComparative evaluation of compound response\u003c\/li\u003e\n\u003cli\u003eInformation to support doctor-led selection of appropriate complementary compounds\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNaturaMatch Molecular™ Advanced\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNaturaMatch Molecular™ includes the core natural-compound response profiling available in NaturaMatch™, with an additional layer of molecular cancer-cell analysis.\u003c\/p\u003e\n\u003cp\u003eThe Advanced profile includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCirculating tumour cell assessment\u003c\/li\u003e\n\u003cli\u003eResponse profiling against more than 50 selected natural substances and plant extracts\u003c\/li\u003e\n\u003cli\u003eGene-expression profiling of the patient's cancer cells\u003c\/li\u003e\n\u003cli\u003eAssessment of cancer-cell resistance-related factors\u003c\/li\u003e\n\u003cli\u003eDeeper molecular information to support individualized treatment planning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis provides additional insight not only into \u003cstrong\u003ewhich compounds demonstrate a response\u003c\/strong\u003e, but also into selected molecular characteristics of the patient's cancer cells.\u003c\/p\u003e\n\u003cp\u003eThe Advanced option is therefore designed for patients and doctors who require a more comprehensive biological picture.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES NATURAMATCH™ DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTests the Patient's Own Cancer Cells\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNaturaMatch™ does not rely solely on generalized population-level recommendations. It evaluates selected compounds against cancer cells isolated from the individual patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized Natural Compound Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDifferent patients may demonstrate different cellular responses to the same compound. NaturaMatch™ helps identify these individual differences.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad Natural Compound Panel\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe laboratory evaluates more than 50 selected natural substances and plant extracts rather than focusing on only one or two supplements.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIncludes Circulating Tumour Cell Assessment\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCTC information provides an additional biological reference alongside the compound-response findings.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard and Advanced Options\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003ePatients can select focused natural-compound profiling or a more comprehensive molecular version depending on the level of information required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Integrative Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe findings provide additional laboratory information that a doctor may consider together with conventional cancer treatment, medical history, medications and the patient's overall clinical condition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Guesswork\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps move natural-compound selection away from a purely trial-and-error approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Individualized Information\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eEvaluates laboratory response using cancer cells obtained from the individual patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompares Multiple Natural Compounds\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAllows healthcare professionals to review relative responses across a broad panel of selected substances.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports More Focused Supplement Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay help reduce unnecessary use of compounds showing limited relevance within the laboratory assessment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplements Conventional Cancer Care\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe information may be incorporated into a broader, doctor-supervised oncology strategy rather than being used as a replacement for established cancer treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOffers Deeper Molecular Insight\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eNaturaMatch Molecular™ provides additional gene-expression and resistance-related information for patients requiring a more advanced cancer-cell profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHO NATURAMATCH™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNaturaMatch™ may be considered for individuals who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave an established cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eare considering natural compounds as part of an integrative oncology program\u003c\/li\u003e\n\u003cli\u003eare already taking multiple supplements and want a more structured approach\u003c\/li\u003e\n\u003cli\u003ewant laboratory-based information to support natural-compound selection\u003c\/li\u003e\n\u003cli\u003ewant to complement conventional oncology care with personalized biological information\u003c\/li\u003e\n\u003cli\u003erequire additional information after previous treatment\u003c\/li\u003e\n\u003cli\u003ewant to reduce unnecessary trial-and-error when considering complementary compounds\u003c\/li\u003e\n\u003cli\u003ehave been advised by their treating doctor to undertake personalized cancer-cell response profiling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNaturaMatch Molecular™ may be particularly relevant when deeper information about cancer-cell gene expression and resistance characteristics is required.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNaturaMatch™ and NaturaMatch Molecular™ are personalized laboratory response-profiling tests intended to provide additional information for professional cancer-care planning.\u003c\/p\u003e\n\u003cp\u003eThey are not standalone diagnostic tests and are not intended to independently diagnose, treat, cure or prevent cancer.\u003c\/p\u003e\n\u003cp\u003eA laboratory response to a natural substance does not guarantee that the same response will occur clinically within the patient's body.\u003c\/p\u003e\n\u003cp\u003eNatural substances and supplements may interact with chemotherapy, radiotherapy, targeted therapy, immunotherapy, hormonal treatment, prescription medications or other medical interventions.\u003c\/p\u003e\n\u003cp\u003eAll results must therefore be interpreted by appropriately qualified healthcare professionals together with the patient's diagnosis, medical history, current treatment and overall clinical condition.\u003c\/p\u003e\n\u003cp\u003eNaturaMatch™ is intended to \u003cstrong\u003esupport informed clinical decision-making, not replace established cancer treatment or professional medical judgement.\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Standard","offer_id":51266122383396,"sku":"CTPO-NATM-STD","price":11188.0,"currency_code":"MYR","in_stock":true},{"title":"Advanced","offer_id":51266122416164,"sku":"CTPO-NATM-MOL","price":13888.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMNaturaMatch-Standard.png?v=1786765263"},{"product_id":"advanced-genetic-testing","title":"Advanced Genetic Testing","description":"\u003cp\u003e\u003cstrong\u003ePersonalized Genetic \u0026amp; Molecular Health Profiling\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdvanced Genetic Testing is a collection of specialized laboratory tests designed to provide deeper insight into an individual's genetic, molecular and chromosomal health.\u003c\/p\u003e\n\u003cp\u003eDifferent tests answer different health questions. Depending on the selected variant, testing may support early cancer-related screening, inherited disease-risk profiling, personalized weight-management planning or investigation of chromosomal abnormalities.\u003c\/p\u003e\n\u003cp\u003eFour testing options are available:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEarly Cancer Detection\u003c\/strong\u003e\u003cbr\u003eBlood-based DNA methylation screening for selected cancer-related signals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Disease Risk Profiling\u003c\/strong\u003e\u003cbr\u003eGenetic profiling for selected cancer predisposition and chronic disease-related risks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized Weight Management\u003c\/strong\u003e\u003cbr\u003eGenetic profiling of selected factors associated with metabolism, appetite, fat storage and lifestyle response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChromosomal Diagnostics\u003c\/strong\u003e\u003cbr\u003eChromosomal microarray analysis for selected chromosomal abnormalities, including microdeletions, microduplications and aneuploidies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT ADVANCED GENETIC TESTING IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdvanced Genetic Testing brings together several specialized laboratory assessments under one precision-health testing platform.\u003c\/p\u003e\n\u003cp\u003eRather than providing the same test to every individual, the appropriate test is selected according to the person's health objective, medical history and professional recommendation.\u003c\/p\u003e\n\u003cp\u003eThe four available testing options cover different areas of health:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEarly Cancer Detection\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to identify selected abnormal DNA methylation patterns associated with cancer-related biological changes.\u003c\/li\u003e\n\u003cli\u003eThe test evaluates methylation signals involving selected tumour suppressor genes across multiple common cancer-related areas.\u003c\/li\u003e\n\u003cli\u003eIt is intended to provide additional information that may support earlier investigation and ongoing professional monitoring.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Disease Risk Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to assess selected inherited genetic variations associated with cancer predisposition and chronic disease risks.\u003c\/li\u003e\n\u003cli\u003eThe profile may provide information relating to selected cancer-associated genes together with genetic tendencies involving cardiometabolic, endocrine and autoimmune-related health conditions.\u003c\/li\u003e\n\u003cli\u003eIt supports a more personalized approach to long-term risk awareness and preventive health planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized Weight Management\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to assess selected genetic factors associated with metabolism, appetite regulation, fat storage and response to nutrition and physical activity.\u003c\/li\u003e\n\u003cli\u003eThe results may provide additional insight into why individuals respond differently to similar diet, exercise and weight-management strategies.\u003c\/li\u003e\n\u003cli\u003eThe information can support more individualized nutrition, activity and lifestyle planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChromosomal Diagnostics\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to identify selected abnormalities involving chromosome number or chromosomal DNA segments.\u003c\/li\u003e\n\u003cli\u003eThe analysis may detect chromosomal changes including microdeletions, microduplications and aneuploidies.\u003c\/li\u003e\n\u003cli\u003eDepending on the clinical indication, it may support prenatal or postnatal investigation of developmental, congenital or chromosomal concerns.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eHOW ADVANCED GENETIC TESTING WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe exact process depends on the selected test.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEarly Cancer Detection\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eA professionally collected blood sample is analysed for selected DNA methylation patterns associated with cancer-related biological changes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Disease Risk Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAn oral swab is collected to obtain DNA for genetic analysis and health-risk profiling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized Weight Management\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAn oral swab is used to obtain DNA for analysis of selected genetic factors associated with metabolism, appetite, nutrition and lifestyle response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChromosomal Diagnostics\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eAn appropriate blood or amniotic-fluid sample is collected according to the clinical indication and analysed for selected chromosomal abnormalities.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAll results should be professionally interpreted together with the individual's health history and relevant clinical findings.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES ADVANCED GENETIC TESTING DIFFERENT?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFour Specialized Testing Options\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eOne platform provides access to four distinct areas of advanced genetic and molecular assessment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalized Test Selection\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe individual selects or is professionally recommended the test most relevant to the health question being investigated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSimple Sample Collection\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eDepending on the test selected, testing may require only a blood sample or oral swab. Chromosomal testing may require a specialized clinical sample.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGoes Beyond Routine Health Screening\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe tests provide genetic, molecular or chromosomal information that is generally not available through routine health screening alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Preventive Health Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSelected tests may help identify health areas that deserve greater attention, monitoring or professional investigation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Interpretation\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eResults are intended to support informed healthcare decisions and should always be interpreted within the appropriate clinical context.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Biological Insight\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps reveal selected genetic, molecular or chromosomal information that may not be apparent through routine tests.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Earlier Risk Awareness\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSelected profiles can help identify areas where closer monitoring or further medical investigation may be appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnables More Personalized Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eResults may support more individualized approaches to screening, lifestyle management and preventive health strategies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMultiple Health Applications\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe testing platform covers cancer-related screening, chronic disease risk, weight management and chromosomal assessment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Testing Options\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eBlood and oral-swab collection options make several of the tests straightforward to incorporate into professional health-assessment programs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHO ADVANCED GENETIC TESTING IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdvanced Genetic Testing may be considered for individuals who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ewant deeper insight into their genetic or molecular health\u003c\/li\u003e\n\u003cli\u003eare interested in proactive and preventive health planning\u003c\/li\u003e\n\u003cli\u003ehave a personal or family history of cancer or chronic disease\u003c\/li\u003e\n\u003cli\u003ewant additional information beyond conventional health screening\u003c\/li\u003e\n\u003cli\u003eare seeking a more personalized weight-management strategy\u003c\/li\u003e\n\u003cli\u003erequire professional investigation of suspected chromosomal abnormalities\u003c\/li\u003e\n\u003cli\u003eare undergoing executive, preventive or longevity-related health assessment\u003c\/li\u003e\n\u003cli\u003ehave been advised by a healthcare professional to undertake additional genetic or molecular testing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe appropriate test should be selected according to the individual's health objective and clinical circumstances.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdvanced Genetic Testing provides genetic, molecular and chromosomal information intended to support professional health assessment and decision-making.\u003c\/p\u003e\n\u003cp\u003eResults should not be interpreted independently.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eEarly Cancer Detection\u003c\/strong\u003e variant is a screening and investigation-support test and does not independently confirm or exclude cancer.\u003c\/p\u003e\n\u003cp\u003eGenetic risk results do not guarantee that an individual will or will not develop a particular disease.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003ePersonalized Weight Management\u003c\/strong\u003e profile does not diagnose the cause of obesity or guarantee weight-loss outcomes.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eChromosomal Diagnostics\u003c\/strong\u003e variant does not detect every possible genetic or chromosomal condition.\u003c\/p\u003e\n\u003cp\u003eAll results must be interpreted by appropriately qualified healthcare professionals together with medical history, family history, symptoms, physical findings and other relevant investigations.\u003cbr\u003e\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Early Cancer Detection","offer_id":51275618975780,"sku":"CTPD-AGT-ECD","price":2388.0,"currency_code":"MYR","in_stock":true},{"title":"Chronic Disease Risk Profiling","offer_id":51275619008548,"sku":"CTPD-AGT-CDR","price":2388.0,"currency_code":"MYR","in_stock":true},{"title":"Personalized Weight Management","offer_id":51275697618980,"sku":"CTPD-AGT-PWM","price":1988.0,"currency_code":"MYR","in_stock":true},{"title":"Chromosomal Diagnostics","offer_id":51275697651748,"sku":"CTPD-AGT-CHR","price":5388.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMAdvancedGeneticTesting.png?v=1786942664"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/collections\/website_black_white_f6c6ec6c-c90a-4c6b-98e1-3ade313df3c4.jpg?v=1663829183","url":"https:\/\/cytolifeasia.com\/ar\/collections\/immune-booster.oembed","provider":"CytoLife","version":"1.0","type":"link"}